Navigation Links
Cardium Completes Preferred Stock Financing
Date:7/19/2013

SAN DIEGO, July 19, 2013 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today announced the completion of the second tranche of its previously described registered direct offering consisting of an additional 1,656 shares of Series A convertible preferred stock for gross proceeds of approximately $1.7 million, bringing the total gross proceeds of the offering to approximately $4.0 million.  The shares were offered and sold pursuant to a prospectus supplement dated April 5, 2013 of a prospectus dated August 27, 2010, which is part of a registration statement on Form S-3 (Registration No. 333-168693) that was declared effective by the SEC on August 27, 2010.  A detailed description of the terms of the securities purchase agreement as well as the rights, privileges and preferences of the Series A Convertible Preferred Stock is contained in the Company's Current Report on Form 8-K which was filed with the SEC on April 5, 2013. 

(Logo:  http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO)

About Cardium         

Cardium is an asset-based health sciences and regenerative medicine company focused on the acquisition and strategic development of innovative products and businesses with the potential to address significant unmet medical needs and having definable pathways to commercialization, partnering or other economic monetizations. Cardium's current portfolio includes LifeAgain medical data analytics, Tissue Repair Company, Cardium Biologics, and the Company's To Go Brands® nutraceutical business. The Company's lead commercial product, Excellagen® topical gel for wound care management, has received FDA clearance for marketing and sale in the United States.  Cardium's lead clinical development product candidate Generx'/>"/>

SOURCE Cardium Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care
2. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
3. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
4. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
5. Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
6. Cardium Announces Excellagen Poster Presentatons At Desert Foot 9th Annual High Risk Diabetic Foot Conference
7. Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments
8. Cardium Announces Presentaton at The 2013 Cell & Gene Therapy Forum
9. Cardium Receives ISO Certification for Excellagen
10. Cardium Announces $4.0 Million Preferred Stock Financing And Reports On Exchange Listing Compliance
11. Cardium Presents Year-End 2012 Financial Results And Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... DUBLIN , June 02, 2015 ... the addition of the "Global Neurodegenerative Diseases ... The global neurodegenerative diseases market to grow ... 2014-2019. This report covers the present ... neurodegenerative diseases market for the period 2015-2019. To ...
(Date:6/3/2015)... , June 3, 2015  Armetheon, Inc., a ... for cardiovascular diseases, today announced that Sanjay ... Chief Executive Officer, effective immediately. Dr. Kakkar brings ... high-growth enterprises, with a successful track record in ... health. With expertise that includes the development of ...
(Date:6/3/2015)... , June 3, 2015 TWi ... that it has received final approval from the ... its Abbreviated New Drug Application (ANDA) for Guanfacine ... Pharmaceutical,s Intuniv®.  TWI,s marketing partner, Par Pharmaceuticals, will ... Intuniv® is indicated for the treatment ...
Breaking Medicine Technology:Global Neurodegenerative Diseases Market 2015-2019 - Reformulation of Marketed Drugs 2Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 2Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 4
... Belgium, March 19, 2012 ADDS A ... SIMPLE ANTIBODY™ PLATFORM   arGEN-X announces today ... the creation of truly differentiated human antibody therapeutics. ... therapeutic antibodies in the human body by engineering of ...
...  Kensey Nash Corporation (NASDAQ: KNSY ) today ... agreement with St. Jude Medical which resolves all disputes ... closure device licenses, as well as other related claims. ... agreed to extend their collagen supply agreement through 2017 ...
Cached Medicine Technology:Argen-X Launches NHance™ Technology to Generate Better Human Antibody Therapies 2Argen-X Launches NHance™ Technology to Generate Better Human Antibody Therapies 3Argen-X Launches NHance™ Technology to Generate Better Human Antibody Therapies 4Kensey Nash Announces Mediated Settlement With St. Jude Medical in Angio-Seal License Disputes and 5 Year Extension and Expansion of Collagen Supply Agreement 2Kensey Nash Announces Mediated Settlement With St. Jude Medical in Angio-Seal License Disputes and 5 Year Extension and Expansion of Collagen Supply Agreement 3Kensey Nash Announces Mediated Settlement With St. Jude Medical in Angio-Seal License Disputes and 5 Year Extension and Expansion of Collagen Supply Agreement 4Kensey Nash Announces Mediated Settlement With St. Jude Medical in Angio-Seal License Disputes and 5 Year Extension and Expansion of Collagen Supply Agreement 5Kensey Nash Announces Mediated Settlement With St. Jude Medical in Angio-Seal License Disputes and 5 Year Extension and Expansion of Collagen Supply Agreement 6
(Date:6/3/2015)... TN (PRWEB) June 03, 2015 On ... around the world will gather in their local communities ... Hundreds of cities across the U.S. and abroad will ... to bring attention to the ongoing challenges of cancer ... a cancer diagnosis can be fruitful, rewarding, and inspiring., ...
(Date:6/3/2015)... June 03, 2015 DailyEndorphin is pleased ... programming module. With this highly configurable new offering, ... report on many components of its wellness programming for ... additional charge. , With this new module, annual clients ... challenges, (2) Create participant surveys, (3) Continually report on ...
(Date:6/3/2015)... Foot and Ankle Specialists of ... ( Clarksville Division ) was recently presented with ... Advanced Wound Care (SAWC) and the American Podiatric Medical ... The Conference was held on April 29-May 3, ... San Antonio, TX. , Dr. Casey Friske graduated ...
(Date:6/3/2015)... Tel-Aviv, Israel (PRWEB) June 03, 2015 ... mass-notification, multi-channel solutions, has showcased its new branding by ... , "The new brand identity: the logo ... from red, to green, the tagline – To Know. ... the new path evigilo is charting. A global, borderless ...
(Date:6/2/2015)... Concorde Career Colleges, Inc., announced today the appointment ... manage day-to-day operations for the privately held career college ... to help our Concorde team deliver on our commitment ... part due to reports like Beyond College Rankings from ... and Portland.” , Bell brings 14 years of executive ...
Breaking Medicine News(10 mins):Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 2Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 3Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 4Health News:DailyEndorphin Launches Wellness "Events" Portal 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Receives Award at the Spring 2015 Symposium of Advanced Wound Care Conference 2Health News:Keep calm! evigilos' "sun" will come out tomorrow – to know, to act, in time. 2Health News:Concorde Career Colleges Announces New President and COO 2
... ... well suited for compounding active pharmaceutical ingredients into silicones in a safe and ... ... http://www.nusil.com ), a leading formulator and manufacturer of silicone compounds for the healthcare ...
... technique using tissue from those below-the-waist "love handles" improves ... adequate fat sources elsewhere, a small Johns Hopkins study ... less complicated than other options for surgeons as well, ... the Johns Hopkins University School of Medicine describe the ...
... Ill. They were illiterate farmers, builders and servants, but ... by burying it within their homes. A new study ... more than 1,000 years ago in central Belize begins to ... anthropology professor Lisa J. Lucero, appears in the Journal ...
... around the world will gather in New Orleans, LA, from ... (DDW ), the premiere scientific conference in the fields ... advance of the meeting, please join us for a telebriefing ... leading research and hot topics to be presented at DDW ...
... Brenda ... , ... Brenda Song is an accomplished and well known American actress, singer and model. Brenda decided ... make working on a set more manageable and less complicated. Brenda had successful LASIK ...
... WebLOQ’s LOQMail ... , ... WebLOQ, Inc ., a leader in privacy solutions for secure and compliant business communications, ... Resource Service, Inc. (MARSI) to ensure the security of its client’s patient medical ...
Cached Medicine News:Health News:NuSil Technology Announces Completion of Clean Room Facilities 2Health News:'Love handles' repurposed for breast reconstruction in women without enough belly fat 2Health News:Classic Maya history is embedded in commoners' homes 2Health News:Classic Maya history is embedded in commoners' homes 3Health News:DDW 2010 telebriefing: Preview the latest research and hot topics 2Health News:Brenda Song LASIK video a hit on You Tube 2Health News:Brenda Song LASIK video a hit on You Tube 3Health News:WebLOQ Selected By MARSI to Streamline Medical Audit Reviews From Dispersed Healthcare Community 2Health News:WebLOQ Selected By MARSI to Streamline Medical Audit Reviews From Dispersed Healthcare Community 3Health News:WebLOQ Selected By MARSI to Streamline Medical Audit Reviews From Dispersed Healthcare Community 4
IDS Rapid STR, a microbial identification system....
IDS Rapid NH, a microbial identification system....
Versatrek 240 is versatile as four tests can be performed on one platform such as blood culture, sterile body fluids, mycobacteria and mycobacteria susceptibility testing. This model comes equipped w...
The Riboprinter microbial characterization system provides the speed, accuracy and resolution needed to identify microorganisms and characterize them efficiently and consistently. These determination...
Medicine Products: